Myriad Genetics | MYGN - Equity Capital And Reserves



Myriad Genetics reported $704.9M in Equity Capital and Reserves for its fiscal quarter ending in March of 2025.


Equity Capital And Reserves Change Date
Agilent USD 6.37B 234M Jul/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Bio-Rad Laboratories USD 7.13B 449.3M Jun/2025
Bruker USD 1.87B 33.9M Jun/2025
Danaher USD 52.33B 1.48B Jun/2025
Exact Sciences USD 2.47B 72.51M Jun/2025
Hologic USD 4.84B 223.8M Jun/2025
Illumina USD 2.26B 110M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Mettler Toledo International USD -258793000 76.81M Jun/2025
Myriad Genetics USD 704.9M 3.8M Mar/2025
Quest Diagnostics USD 7.23B 299M Jun/2025
Quidel USD 2.79B 204.5M Jun/2025
Repligen USD 1.99B 12.76M Mar/2025
Revvity USD 7.64B 29.74M Mar/2025
Standard Biotools USD 424.54M 47.18M Jun/2025
Thermo Fisher Scientific USD 49.36B 227M Mar/2025
Veracyte USD 1.22B 26.12M Jun/2025
Waters USD 2.16B 197.42M Jun/2025